Н. С. Руднева
Tula State University · 44 works · 88 citations · h-index 4
Top works
- Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia
- Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations
- Inverse psoriasis and psoriasis of ‘difficult’ localizations: Effectiveness of netakimab
- Efficacy and safety of dupilumab in complex treatment of patients with severe atopic dermatitis
- Monitoring of macrolide resistanceassociated mutations in Mycoplasma genitalium in Russia
- The Aexperience of the Organization and the Screening of Pregnant Women for the Purpose of Detecting Sexually Transmitted Infections, in the Framework of the Regional Program of the Tula Region
- Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice
- Issues of use of hepatoprotectors in psoriasis: Indications and effectiveness
- Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
- Certolizumab pegol for treatment of severe plaque psoriasis: local experience
- The rates of mutations associated with macrolide resistance in Mycoplasma genitalium among patients with non-gonococcal sexually transmitted infections in Smolensk and Tula
- Pustular psoriasis treated with IL-17a antibody secukinumab
- Macrolide and fluoroquinolone resistance in Mycoplasma genitalium isolated from pregnant women in Russia and Belarus
- Rare Forms of Exanthems in Pediatric Clinical Practice
- Case of bullous pemphigoid in patient with psoriasis, after new coronavirus infection COVID‑19
- Early administration of genetically engineered biological agents as effective secondary prevention of psoriatic arthritis
- Hematidrosis or artistic dermatitis?
- Cytokine profile and predictors of the efficacy of genetically engineered biological therapy for psoriasis and psoriatic arthritis: a literature review
- THE USE OF TOFACITINIB FOR TREATMENT PATIENTS WITH PSORIASIS IN CONDITIONS OF THE DERMATOLOGICAL HOSPITAL
- RISK ANALYSIS AND ADVERSE EVENTS OF TNF-Α AND IL-17A INHIBITORS IN PSORIASIS